Implantable Medical Electronics

Höfundur: Vinod Kumar Khanna (Útgáfa: 2)
Implantable Medical Electronics

Kaup valmöguleikar

Í þessari ítarlega uppfærðu og auknu útgáfu er fjallað um nýjustu framfarir á sviði ígræðanlegra lækningatækja. Í fyrsta hlutanum eru grundvallarhugtök og meginreglur kynnt ásamt ítarlegu yfirliti yfir þá þekkingu á rafeindatækni sem nauðsynleg er á þessu sviði. Í öðrum hlutanum er fjallað um örvunaraðferðir fyrir hjarta, heila, mænu og taugakerfið sem tengir heila og mænu við helstu líffæri, auk gervihluta fyrir eyru og augu.

Í bókinni er fjallað um fjögur meginsvið ígræðanlegrar rafeindatækni:

  • Ígræðanlega taugamagnara sem gera kleift að skrá taugaboð af nákvæmni fyrir rannsóknir í taugaverkfræði.
  • Ígræðanlega púlsgjafa sem stýra starfsemi sjúkra líffæra.
  • Ígræðanlega skynjara sem gera kleift að meta áhrif meðferðar og fylgjast með líffræðilegum mæligildum sjúklinga.
  • Lyfjagjafarkerfi sem tryggja nákvæma skömmtun lyfja til þeirra líkamshluta sem þarfnast meðferðar.

Í þessari útgáfu eru nýir kaflar um snjalllinsur, augnígræði og þráðlausa hylkisspeglun. Einnig er fjallað um klukku- og tímarásir, púlsgjafarásir, taugamagnara, rafhlöður, lífefni, lífsamrýmanleika og margt fleira. Sérstakur kafli er helgaður mikilvægum álitaefnum um netöryggi og trúnað í tengslum við ígræðanleg tæki.

Spurningar og verkefni í lok hvers kafla hjálpa lesendum að nýta efnið í framkvæmd. Implantable Medical Electronics: Prosthetics, Drug Delivery, and Health Monitoring er yfirgripsmikið þverfaglegt rit fyrir framhaldsnema í rafmagnsverkfræði, rafeindamælitækni og lífeindaverkfræði.

Nánar um bókina

Útgefandi
Springer Nature
ISBN
9783031998683
Print ISBN
9783031998676
Format
ePub
Útgáfa
2
Höfundar
Vinod Kumar Khanna
Tungumál
English
Útgefið
2026-01-01
Prent takmörkun á líftíma
100
Prent takmörkun
2
Afritunar takmörkun
2

Kaflar

  • Implantable Medical Electronics
  • Preface to the Second Edition
  • Preface to the First Edition
  • About This Book
  • Why This Book Was Written?
  • For Whom This Book Was Written?
  • Layout of the Book
  • Acknowledgments
  • Contents
  • About the Author
  • 1. Introduction, Scope, and Overview
  • 1.1 Electronics
  • 1.2 Medical Electronics
  • 1.3 Implantable Medical Electronics
  • 1.4 Organization of the Book
  • 1.5 Discussion and Conclusions
  • Part I: Basic Concepts and Principles
  • 2. Diagnostic and Therapeutic Roles of Implantable Devices in the Human Electrical Machine: A Quick Primer
  • 2.1 Introduction
  • 2.2 Medical Devices and Medicinal Products
  • 2.3 Medical Device Classification
  • 2.4 Noninvasive and Invasive Medical Procedures and Devices
  • 2.5 Implantable Medical Devices
  • 2.6 Passive and Active Implantable Devices
  • 2.7 Active Implantable Devices
  • 2.7.1 Implantable Neural Amplifiers
  • 2.7.2 Implantable Electronic Systems for Electrical Stimulation
  • 2.7.3 Implantable Electronic Systems for Continuous Health Status Monitoring
  • 2.7.4 Implantable Drug Delivery Systems
  • 2.8 Brief Historical Background
  • 2.9 Electrical System of the Human Body
  • 2.10 Bioelectricity
  • 2.10.1 Generation of Bioelectricity by Cells
  • 2.10.2 Membrane Potential
  • 2.10.3 Action Potential
  • 2.11 Discussion and Conclusions
  • 3. Generic Implant Architecture and Organization
  • 3.1 Introduction
  • 3.2 External Part of the Implantable Device
  • 3.2.1 Induction Charger
  • 3.2.2 Nonresonant and Resonant Coupling
  • 3.2.3 Antenna
  • 3.2.4 Transceiver
  • 3.2.5 USB Port
  • 3.3 The Inner Structural Layout of the Implant
  • 3.3.1 The Secondary Coil
  • 3.3.2 Rectifier, Filter, and Chargeable Battery
  • 3.3.3 Voltage Regulator
  • 3.3.3.1 Linear Regulator
  • 3.3.3.2 Switch-Mode Power Supply
  • 3.3.3.3 Bandgap Voltage Reference Circuit
  • 3.3.4 Power Saving and Economization Unit
  • 3.3.5 Battery-Less Implant
  • 3.4 Data Telemetry Unit
  • 3.5 Central Processing Unit
  • 3.6 Memory Storage
  • 3.7 Analog Front End
  • 3.8 Electronic Block or Feature Grouping
  • 3.9 Discussion and Conclusions
  • 4. Dilemmas and Enigmas of Implantable IC Design
  • 4.1 Introduction
  • 4.2 CMOSFET: The Digital Workhorse
  • 4.2.1 CMOS Processes
  • 4.2.2 CMOS Combinational Logic
  • 4.2.3 CMOS Advantages
  • 4.3 Single-Chip Versus Multiple-Chip Design
  • 4.4 Speed and Threshold Voltage Trade-Off
  • 4.5 Matching the Threshold Voltages of N- and P-Channel Devices
  • 4.6 Rise of Leakage Currents in Deep Submicron Transistors
  • 4.6.1 Gate-Induced Drain Leakage
  • 4.6.2 Leakage Current Flow Through the Gate Oxide
  • 4.7 Reliability Degradation of Deep Submicron Transistors
  • 4.7.1 Stress-Induced Leakage Current and Soft Breakdown
  • 4.7.2 Negative-Bias Temperature Instability
  • 4.7.3 CMOSFET Noise Sources
  • 4.7.3.1 Thermal Noise
  • 4.7.3.2 Flicker Noise
  • 4.7.3.3 Shot Noise
  • 4.7.3.4 Generation–Recombination Noise
  • 4.7.3.5 Popcorn Noise
  • 4.8 Input DC Offset
  • 4.9 Drain-Induced Barrier Lowering
  • 4.10 Channel Lengthening
  • 4.11 Revision of Transistor Models for Implantable Electronics
  • 4.12 Analog Signal Processing
  • 4.13 Electrostatic Discharge Failure Limit and Protection
  • 4.14 Digital Signal Processing
  • 4.15 Memory Design Artifices
  • 4.15.1 Sense Amplifiers
  • 4.15.1.1 Voltage-Mode Sense Amplifier
  • 4.15.1.2 Current-Mode Sense Amplifier
  • 4.15.1.3 Charge Transfer Sense Amplifier
  • 4.15.2 Soft Errors
  • 4.16 IC Testing and Evaluation
  • 4.17 Discussion and Conclusions
  • 5. Neural Stimulation and Charge Balancing Approaches
  • 5.1 Introduction
  • 5.2 Monopolar and Bipolar Electrodes
  • 5.3 Monophasic and Biphasic Waveforms
  • 5.4 Functional Circuit Blocks
  • 5.4.1 CMOS Switch
  • 5.4.2 Digital-to-Analog Converter
  • 5.4.3 Analog-to-Digital Converter
  • 5.4.4 Voltage and Current Sources
  • 5.4.5 Current Source Versus Current Sink
  • 5.4.6 Current Mirror
  • 5.4.7 Voltage-to-Current Converter
  • 5.4.8 Voltage Multiplier
  • 5.4.9 Boost Converter
  • 5.4.10 Timer Circuit
  • 5.4.11 Driver Circuit
  • 5.5 Current-, Voltage-, and Charge-Mode Stimulation
  • 5.5.1 Current-Mode Stimulation
  • 5.5.2 Voltage-Mode Stimulation
  • 5.5.3 Charge-Mode Stimulation
  • 5.6 Charge Balancing
  • 5.6.1 Passive Charge Balancing
  • 5.6.1.1 Blocking Capacitor
  • 5.6.1.2 Short-Circuiting of Electrodes
  • 5.6.2 Active Charge Balancing
  • 5.6.2.1 Charge Surveillance
  • 5.6.2.2 Pulse Insertion
  • 5.7 Discussion and Conclusions
  • 6. Implant Clocking and Timing Circuits
  • 6.1 Introduction
  • 6.2 Clock Generators
  • 6.3 Oscillator Circuits
  • 6.3.1 Crystal Oscillator (XO)
  • 6.3.2 Resistance–Capacitance Oscillator
  • 6.3.3 Crystal-Based CMOS Square Wave Oscillators
  • 6.3.4 Multivibrator Circuits Using Logic Gates
  • 6.3.4.1 Monostable Multivibrator
  • 6.3.4.2 Astable Multivibrator
  • 6.3.4.3 Bistable Multivibrator
  • 6.4 Timer ICs and Timing Circuits
  • 6.4.1 Block Diagram
  • 6.4.2 Pin Diagram
  • 6.4.3 Monostable Mode for Timer or Time Delay Function
  • 6.4.4 Monostable Mode for Frequency Division
  • 6.4.5 Monostable Mode for Missing Pulse Detection
  • 6.4.6 Pulse-Width Modulation
  • 6.4.7 Astable Mode for Pulse Generation
  • 6.4.8 Pulse Amplitude Modulation
  • 6.4.9 Pulse Position Modulation
  • 6.5 Discussion and Conclusions
  • 7. Electrostimulation Pulse Generators
  • 7.1 Introduction
  • 7.2 Electrical Pulse and Pulse Parameters
  • 7.3 Pulse Generator
  • 7.4 Power Supply
  • 7.5 Pulse Timing Control Unit
  • 7.6 Timer IC-Based Pulse Generator
  • 7.7 Microcontroller-Based Pulse Generator
  • 7.7.1 Why Microcontroller-Based Pulse Generators?
  • 7.7.2 User Interfaces
  • 7.7.3 Main Tasks of Microcontroller
  • 7.7.4 Frequency Division by Counters
  • 7.7.5 Changing Other Parameters of the Pulses
  • 7.7.6 FET-Based Methods of Amplitude Control
  • 7.8 Discussion and Conclusions
  • 8. Biomaterials for Implants
  • 8.1 Aims and Scope of Biomaterials
  • 8.2 Defining Biocompatibility
  • 8.3 Responses of Tissues to Materials
  • 8.4 Metallic Biomaterials
  • 8.4.1 Commonly Used Materials
  • 8.4.2 Corrosion
  • 8.4.3 Processing of Metals
  • 8.4.4 Surface Treatment
  • 8.4.5 Surface Coating
  • 8.4.6 Cleaning and Sterilization
  • 8.4.7 Biodegradable Metals
  • 8.5 Bioceramics
  • 8.5.1 Types of Ceramics
  • 8.5.2 Dental Ceramics
  • 8.5.3 Corrosion of Ceramics
  • 8.5.4 Toxic Effects
  • 8.6 Biocompatible Polymeric Materials
  • 8.6.1 Need of Polymeric Materials
  • 8.6.2 Special Properties of Polymers
  • 8.6.3 Polymer Integration
  • 8.7 Discussion and Conclusions
  • 9. Batteries for Implants
  • 9.1 Introduction
  • 9.2 Lithium/Iodine–Polyvinylpyridine Battery
  • 9.3 Lithium–Manganese Dioxide Battery
  • 9.4 Lithium/Carbon Monofluoride Battery
  • 9.5 Lithium/Carbon Monofluoride–Silver Vanadium Oxide Hybrid Battery
  • 9.6 High-Rate Lithium/Silver Vanadium Oxide Battery
  • 9.7 High-Rate Lithium–Manganese Dioxide Battery
  • 9.8 High-Rate Lithium/Carbon Monofluoride–Silver Vanadium Oxide Hybrid Battery
  • 9.9 Secondary Lithium-Ion Battery
  • 9.10 Discussion and Conclusions
  • 10. Wireless Communications and Powering of Implants
  • 10.1 Introduction
  • 10.2 Powering the Implant
  • 10.2.1 Through Percutaneous Leads
  • 10.2.2 Wireless Charging
  • 10.3 Inductive Charging
  • 10.3.1 Frequencies Used
  • 10.3.2 Coupling and Loading Variations
  • 10.3.3 Design Considerations
  • 10.3.4 Applications
  • 10.4 Resonance Charging
  • 10.5 Radio Charging
  • 10.5.1 Similarity to Radio Transmission and Reception
  • 10.5.2 Safety Limits
  • 10.6 Biotelemetry
  • 10.6.1 Active Telemetry
  • 10.6.2 Passive Telemetry
  • 10.7 Data Telemetry Uplink: From the Implanted Medical Device to Its External Part
  • 10.7.1 Digital Modulation Techniques: A Quick Relook
  • 10.7.2 Load-Shift Keying and Multilevel Load-Shift Keying
  • 10.7.3 Auxiliary-Carrier Load-Shift Keying
  • 10.7.4 Adaptive Control Load-Shift Keying
  • 10.7.5 Passive Phase-Shift Keying
  • 10.7.6 Pulse Harmonic Modulation
  • 10.8 Data Telemetry Downlink: From the External Part to the Implanted Medical Device
  • 10.8.1 Amplitude-Shift Keying
  • 10.8.2 Frequency-Shift Keying
  • 10.8.3 Phase-Shift Keying
  • 10.9 Discussion and Conclusions
  • 11. Cyber Security and Confidentiality Concerns with Implants
  • 11.1 Introduction
  • 11.2 Apprehensions of Patients Receiving Implants
  • 11.3 Security Requirements
  • 11.4 Causes of Security Breaches
  • 11.4.1 Deliberate Breaches
  • 11.4.2 Unintentional Breaches
  • 11.5 Types of Adversaries
  • 11.6 Design Principles for Implant Security
  • 11.7 Expository Examples of Security Breach Possibilities
  • 11.7.1 Hijacking an Open-Loop Procedure: The Insulin Infusion Pump
  • 11.7.2 Security Analysis of a Closed-Loop System: The Implantable Cardioverter Defibrillator
  • 11.7.3 Security and Privacy of Implantable Biosensors Used for Data Acquisition
  • 11.8 Conflict of Security with Safety, Efficiency, and Usability
  • 11.9 Negative Aspects of Security Scheme
  • 11.10 Protection Without Device Modification
  • 11.11 Discussion and Conclusions
  • Part II: Applications
  • 12. Neural Amplifier Circuits in Implants
  • 12.1 Introduction
  • 12.2 Clock-Based Amplifiers
  • 12.2.1 Switched-Biasing Amplifier
  • 12.2.2 Chopper-Stabilized Amplifier
  • 12.2.2.1 Chopper Amplification Concept
  • 12.2.2.2 Conventional Chopper-Stabilized Amplifier
  • 12.2.2.3 Wide-Bandwidth Chopper-Stabilized Amplifier
  • 12.2.3 Auto-zeroing Amplifier
  • 12.3 Zero-Drift Amplifiers
  • 12.4 Continuous-Time Amplifier Circuits
  • 12.4.1 Operational Transconductance Amplifier
  • 12.4.2 Comparison of OTA with Bipolar Transistor
  • 12.4.3 OTA Versus Operational Amplifier
  • 12.4.4 OTA Operation
  • 12.4.5 Single OTA-Stage CMOS Amplifier
  • 12.4.6 Low Input Capacitance Amplifier
  • 12.5 Discussion and Conclusions
  • 13. Implantable Sensors
  • 13.1 Introduction
  • 13.2 Implantable Blood Pressure Sensor
  • 13.2.1 Capacitive Pressure Sensors
  • 13.2.2 Accelerometers
  • 13.2.3 SAW Sensors
  • 13.3 Predicaments of Implantable Biosensors
  • 13.3.1 Foreign Body Response
  • 13.3.2 Oxygen Shortfall
  • 13.3.3 Enzyme Stability
  • 13.4 Implantable Blood Gas Sensors
  • 13.5 Artificial Pancreas Concept
  • 13.5.1 Metabolite Sensors
  • 13.5.2 Treatment Options for Diabetes
  • 13.5.3 Subcutaneously Implanted Glucose Biosensor
  • 13.6 NO Detection-Based Implantable Inflammation Sensor
  • 13.7 Discussion and Conclusions
  • 14. Cardiac Pacemakers
  • 14.1 Introduction
  • 14.2 Natural and Artificial Pacemakers of the Heart
  • 14.3 Unipolar and Bipolar Stimulation
  • 14.4 The Electrocardiogram Waveform
  • 14.5 Arrhythmias and Pacemaker Indications
  • 14.6 Types of Artificial Pacemakers
  • 14.7 Pacemaker Codes
  • 14.8 Fitting the Pacemaker
  • 14.8.1 Surgery for Pacemaker
  • 14.8.2 Post-operation Follow-Ups
  • 14.9 First Pacemaker Implantation
  • 14.10 Evolution of Pacemaker Electronics
  • 14.10.1 Pulse Generators
  • 14.10.2 Pacemaker Miniaturization
  • 14.11 Software-Based Pacemaker Architecture
  • 14.12 Programmability and Telemetry
  • 14.13 Rate-Responsiveness
  • 14.14 Automatic Safety/Backup Features
  • 14.15 Pacing Leads and Connectors
  • 14.15.1 Lead Construction and Design
  • 14.15.2 Lead Fixation Mechanisms
  • 14.15.3 Lead Materials
  • 14.16 Pacemaker Myths and Misconceptions
  • 14.17 Discussion and Conclusions
  • 15. Implantable Cardioverter Defibrillators
  • 15.1 Introduction
  • 15.1.1 Explanation of VT and VF
  • 15.1.2 Cardioversion
  • 15.2 Difference Between ICD and Pacemaker
  • 15.3 Necessity of ICD
  • 15.4 Historical Background
  • 15.5 ICD Construction
  • 15.6 Epicardial Versus Endocardial (Transvenous) Lead Systems
  • 15.7 Arrhythmia Detection
  • 15.8 Detection Zones
  • 15.9 Algorithms for Detection of Arrhythmias
  • 15.9.1 Algorithms for Single-Chamber ICDs
  • 15.9.2 Algorithms for Dual-Chamber ICDs
  • 15.10 Therapies Administered
  • 15.11 Postimplantation Patient Follow-Up and Monitoring
  • 15.12 Discussion and Conclusions
  • 16. Deep Brain Stimulation
  • 16.1 Introduction
  • 16.2 Movement Disorders
  • 16.2.1 Parkinson’s Disease (PD)
  • 16.2.2 Tremor
  • 16.2.3 Dystonia
  • 16.3 Lesioning Procedures and the Need of DBS
  • 16.3.1 Pallidotomy, Thalamotomy, and Subthalamotomy
  • 16.3.2 Advent of DBS
  • 16.3.3 DBS Versus Lesioning
  • 16.4 Patient Selection/Exclusion Criteria for DBS
  • 16.5 DBS Surgical Methodology
  • 16.6 The DBS System
  • 16.7 Mechanisms of DBS Action
  • 16.8 Risks of DBS Surgery
  • 16.9 DBS for Psychiatric and Neurological Disorders
  • 16.9.1 Major Depression
  • 16.9.2 Obsessive–Compulsive Disorder
  • 16.9.3 Alzheimer’s Disease
  • 16.10 Discussion and Conclusions
  • 17. Epidural Spinal Cord Stimulation
  • 17.1 Introduction and Historical Glimpses
  • 17.2 Epidural Space and Epidural Anesthesia
  • 17.3 SCS Equipment
  • 17.3.1 The Hardware and the Electrodes
  • 17.3.2 Implantable Power Sources
  • 17.3.2.1 The Conventional Non-rechargeable Unit
  • 17.3.2.2 Rechargeable Unit
  • 17.3.2.3 Radio-Frequency Unit
  • 17.4 Mechanisms of Action
  • 17.5 SCS Indications
  • 17.6 Discussion and Conclusions
  • 18. Vagus Nerve Stimulation
  • 18.1 Introduction
  • 18.2 Epileptic Seizures
  • 18.3 Vagus Nerve Stimulation for Medically Refractory Epilepsy
  • 18.4 Promising Areas of VNS Therapy
  • 18.5 Anatomical Basis of VNS
  • 18.6 The VNS System
  • 18.7 Implantation of VNS System
  • 18.8 VNS in Depression
  • 18.9 Reasons for Antidepressive Action of VNS
  • 18.10 Drawbacks of VNS for Depression Treatment
  • 18.11 VNS for Obesity Treatment
  • 18.12 VNS for Rheumatoid Arthritis
  • 18.13 Discussion and Conclusions
  • 19. Diaphragmatic/Phrenic Nerve Stimulation
  • 19.1 Introduction
  • 19.2 Respiration, Phrenic Nerves, and Diaphragm
  • 19.3 Diaphragm Pacing Versus Mechanical Ventilation
  • 19.4 Indications for D/P Nerve Stimulator
  • 19.5 The Pacing System
  • 19.6 Surgical Procedure
  • 19.7 Training, Rehabilitation, and Precautions
  • 19.8 Discussion and Conclusions
  • 20. Sacral Nerve Stimulation
  • 20.1 Introduction
  • 20.2 The Urinary System and Bladder Control Problems
  • 20.3 Indications for SNS
  • 20.4 Diagnosis and Suitability
  • 20.5 The SNS System and Implantation Procedure
  • 20.5.1 The SNS System
  • 20.5.2 Stages of the Implantation Procedure
  • 20.5.2.1 Stage I: Minimally Invasive Screening Test
  • 20.5.2.2 Stage II: Permanent Implantation
  • 20.5.3 Stimulation Parameters
  • 20.6 Discussion and Conclusions
  • 21. Cochlear Implants
  • 21.1 Introduction
  • 21.2 Causes of Hearing Loss
  • 21.2.1 Conductive Hearing Loss
  • 21.2.2 Sensorineural Hearing Loss
  • 21.2.3 Mixed Hearing Loss
  • 21.3 CI Versus Hearing Aid
  • 21.4 Acoustic Versus Electrical Hearing
  • 21.5 Components of the Device
  • 21.5.1 External Functionality
  • 21.5.2 Internal Functionality
  • 21.6 Candidacy for Cochlear Implantation
  • 21.6.1 Presurgery
  • 21.6.2 Surgical Procedure
  • 21.6.3 Postsurgery
  • 21.7 Discussion and Conclusions
  • 22. Retinal Prostheses
  • 22.1 Introduction
  • 22.2 Role of Retina in Vision
  • 22.3 Vision Impairment and Its Remedial Schemes
  • 22.3.1 Age-Related Macular Degeneration
  • 22.3.2 Retinitis Pigmentosa
  • 22.3.3 Evolution of the Concept of Electrical Stimulation of the Retina
  • 22.4 Two Kinds of Retinal Implant
  • 22.4.1 Subretinal Implant
  • 22.4.2 Epiretinal Implant
  • 22.5 Argus II Retinal System
  • 22.6 Alpha IMS Retinal Implant
  • 22.7 Optimal Candidates for Retinal Implants
  • 22.8 Discussion and Conclusions
  • 23. Smart Contact Lenses and Eye Implants
  • 23.1 Introduction
  • 23.2 Types of Wearable and Implantable Lenses for the Eye
  • 23.3 Monitoring of Glucose, Lactate, and Cholesterol Levels in Tear Fluid Using Eye Lenses
  • 23.3.1 Contact Lens with Integrated Glucose Sensor
  • 23.3.2 Contact Lens with Glucose Sensor, Circuit, and Wireless Display
  • 23.3.3 Contact Lens for Glucose Monitoring and Drug Delivery in Diabetic Retinopathy
  • 23.3.4 Fluorescent Contact Lens for Monitoring Glucose via a Smartphone
  • 23.3.5 Contact Lens with Integrated Lactate Sensor
  • 23.3.6 Contact Lens with Cholesterol Sensor
  • 23.4 Contact Lens-Based Lysozyme Detection in Tear Fluid
  • 23.5 Implantable IOL for Aqueous Humor Biomarkers for Central Nervous System Disorders
  • 23.6 Implantable IOL Fluorescence Sensor for Alzheimer’s Disease
  • 23.7 Theranostic Contact Lens for Glaucoma Treatment
  • 23.7.1 Contact Lens with Gold Hollow Nanowire-Based Pressure Sensor
  • 23.7.2 Contact Lens with a Capacitive Pressure Sensor
  • 23.8 Contact Lens for Human–Machine Interaction
  • 23.9 Discussion and Conclusions
  • 24. Wireless Capsule Endoscopy
  • 24.1 Preliminary Background
  • 24.2 Core Components of the Capsule Used in Endoscopy
  • 24.3 Procedure of Capsule Endoscopy
  • 24.4 Applications of Capsule Endoscopy
  • 24.5 Advantages of Capsule Endoscopy
  • 24.6 Shortcomings of Capsule Endoscopy
  • 24.7 Magnetically Guided Capsule Endoscopy
  • 24.7.1 Working of Magnetically Guided Capsule Endoscopy
  • 24.7.2 Types of Magnetic Actuation Systems
  • 24.7.3 Applications, Benefits, and Limitations of MGCE
  • 24.8 Comparison of Capsule Endoscopy with Related Techniques
  • 24.8.1 Capsule Endoscopy Versus Conventional Endoscopy
  • 24.8.2 Capsule Endoscopy Versus Radiographic Techniques
  • 24.8.3 Capsule Endoscopy Versus CT Enteroclysis/MRI
  • 24.8.4 Capsule Endoscopy Versus Push Enteroscopy
  • 24.9 Future Directions and Prospects of Capsule Endoscopy
  • 25. Drug Delivery Implants
  • 25.1 Introduction
  • 25.2 Conventional Drug Delivery Systems
  • 25.2.1 Oral Method
  • 25.2.2 Nasal Method
  • 25.2.3 Pulmonary Method
  • 25.2.4 Transdermal Method
  • 25.2.4.1 Advantages of Transdermal Method
  • 25.2.4.2 Limitations of Transdermal Method
  • 25.2.5 Intravenous Method
  • 25.2.5.1 Intravenous Method for Fast Drug Delivery
  • 25.2.5.2 Intravenous Method for Slow Drug Delivery
  • 25.2.5.3 IV Push and IV Infusion
  • 25.2.5.4 Risks of Intravenous Medication
  • 25.2.5.5 Limitations of Intravenous Medication
  • 25.2.6 Intramuscular Method
  • 25.3 Advantages of IDDSs Over Existing Methods
  • 25.4 Disadvantages of IDDSs Over Existing Methods
  • 25.5 Desirable Properties of Effective Subcutaneous IDDSs
  • 25.6 Biodegradation-Based IDDS Classification
  • 25.6.1 Biodegradable IDDSs
  • 25.6.2 Nonbiodegradable IDDSs
  • 25.7 Passive and Active IDDSs
  • 25.8 Micro- and Nanoscale IDDSs
  • 25.8.1 Microreservoir-Based IDDSs
  • 25.8.1.1 Passive Devices
  • 25.8.1.2 Actively Driven Devices
  • 25.9 Infusion Micropumps for Drug Delivery
  • 25.9.1 Principles of Passive Micropumps
  • 25.9.1.1 Osmotic Principle
  • 25.9.1.2 Spring-Powering Principle
  • 25.9.2 Principles of Active Micropumps
  • 25.9.2.1 Electrostatic Principle
  • 25.9.2.2 Piezoelectric Principle
  • 25.9.2.3 Electrochemical Principle
  • 25.9.2.4 Thermal Principle
  • 25.10 Robotic Capsules for Drug Delivery to the Gastrointestinal Tract
  • 25.11 Advantages and Disadvantages of Capsule Robots
  • 25.12 Discussion and Conclusions
  • Index